Liposomes as Nano Carriers in Cancer Therapy: A Comprehensive Review

Le résumé fourni par la source

Liposomes are artificial vesicles composed of a phospholipid bilayer that can encapsulate both hydrophilic and lipophilic drugs, protecting them from degradation. Since their discovery in the mid1960s, liposomes have revolutionized research and studies. Their biocompatibility and flexibility enable targeted drug delivery at tumor sites, reducing the harm associated with traditional chemotherapy. By delivering high concentrations of drugs directly to tumors, liposomes minimize damage to healthy tissues. A significant advantage of liposomes in cancer treatment is their ability to entrap a variety of hydrophilic anticancer drugs, antifungal agents, and gene therapy derivatives. This property makes liposomes an attractive platform for targeted and efficient drug delivery. This comprehensive review aims to provide an indepth analysis of the current state of liposomebased anti-cancer therapy, highlighting recent advances, challenges, and future perspectives.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.